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ABSTRACT
NKG2D is an activation receptor, which allows NK cells to detect diseased host cells. The
engagement of NKG2D with corresponding ligand results in surface modulation of the receptor
and reduced function upon subsequent receptor engagement. However, it not clear, whether in
addition to modulation, the NKG2D receptor complex and/or its signaling capacity is preserved.
We show here that the prolonged encounter with tumor cell-bound, but not soluble, ligand can
completely uncouple the NKG2D receptor from the intracellular mobilization of calcium and the
exertion of cell-mediated cytolysis. However, cytolytic effector function is intact since NKG2D
ligand-exposed NK cells can be activated via the Ly49D receptor. While NKG2D-dependent
cytotoxicity is impaired, prolonged ligand exposure results in constitutive IFNγ production,
suggesting sustained signaling. The functional changes are associated with a reduced presence
of the relevant signal transducing adaptors DAP-10 and KARAP/DAP-12. That is likely the
consequence of constitutive NKG2D engagement and signaling since NKG2D function and
adaptor expression is restored to normal when the stimulating tumor cells are removed. Thus,
the chronic exposure to tumor cells expressing NKG2D-ligand alters NKG2D signaling and may
facilitate the evasion of tumor cells from NK cell reactions.
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INTRODUCTION
Numerous activation receptors can trigger NK cell-mediated cytotoxic and/or cytokine
responses. The NKG2D receptor is specific for endogenous ligands (i.e. H6O, RAE and MULT1
in mice), which are usually not expressed on normal resting cells but which are readily induced
upon different forms of cellular distress (for a review see
1). Thus the de novo expression of
NKG2D ligands renders cells susceptible to NK cell mediated lysis. On many tumor cell lines of
distinct tissue origins NKG2D-ligands are constitutively expressed. The ectopic expression of
NKG2D-ligands induces the rejection of several transplantable tumor cell lines
2,3.
Despite NKG2D’s prominent role in NK cell activation and T cell co-stimulation, it is
noteworthy that many established tumor cell lines constitutively express NKG2D ligands,
suggesting that tumors can escape NKG2D recognition. Indeed, T and NK cells, which were
infiltrating MICA+ tumors had reduced NKG2D cell surface levels
4,5. In vitro, soluble MICA or
tumor cells expressing MICA induced the down-modulation and degradation of NKG2D
expressed by CD8+ T cells, which led to reduced effector functions
4. In addition, NK cells
derived from NOD mice (a strain of mice prone to autoimmune diabetes) displayed impaired
NKG2D function
6. NKG2D dysfunction and modulation was explained by an interaction of
NKG2D with its ligands, which are aberrantly induced on NOD NK cells upon culture
6.
In general, reduced NKG2D function is thought to be the consequence of and directly
related to the lower NKG2D cell surface levels. However, it has not been determined whether
sustained  NKG2D  engagement  leaves  the  NKG2D  receptor  complex  and/or  its  signal
transduction capacity intact. To this end we established a co-coculture system in which NK cells
are exposed to tumor cells expressing NKG2D ligand. We show that chronic engagement with
tumor cell bound NKG2D ligand can uncouple NKG2D recognition from the exertion of NK
cell mediated target cell lysis. NKG2D dysfunction is explained by striking reduction of the
NKG2D signaling adaptor molecules DAP-10 and KARAP/DAP-12. These findings suggest that
tumor cells expressing NKG2D ligand can efficiently shut down and consequently evade
NKG2D mediated NK cell reactions.
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MATERIALS AND METHODS
Mice. C57BL/6 (B6) were purchased from Harlan (Horst, The Netherlands). KARAPki mice, B6
backcross 9, have been described
7. Animal experimentation followed protocols approved by the
Service Vétérinaire de l’Etat de Vaud.
Cell lines. The cell lines used here were described before
8,9. CHO Pro5 cells were kindly
provided by Wayne Yokoyama, Washington University, MO.
NK cell culture. B6 splenocytes were depleted of B and T cells by with nylon wool and mAb
17A2 (CD3ε, LICR) plus anti rat IgG M450 Dynabeads (Dynal, Oslo, Norway), respectively,
resulting in 20-35% CD3
-NK1.1
+ cells. For kinetic experiments, NK cells were enriched
further  by  negative  selection  using  mAbs  to  F4.80,  CD5  and  B220  (at  suboptimal
concentration), resulting in 70-80% pure NK cells. CFSE (Molecular Probes, Eugene,
OR)–labeled and irradiated (3000 rad) RMA or RMA H60 cells were added at a 1:1 ratio to
NK cells (at 10
6/ml). After 3 days of co-culture in the presence of IL-2 (500ng/ml), remaining
CFSE+ RMA cells were removed using mAbs to CD3ε, MuLV gp70 (RL2.5.6, LICR) and
CD5 (53-7.213.2, LICR) and Dynabeads, yielding in 50-80% NK cells, < 3% T cells and <5%
residual RMA cells.
Flow cytometry. One x10
6 cells were incubated with mAb 24G2 (anti-CD16/32) to reduce
background and stained with the following mAbs: PK136 (NK1.1), 4E5 (Ly49D) (BD
PharMingen, San Diego, CA), 2.4G2 (anti-CD16/32, LICR), NKG2D (R&D systems, Oxon,
UK). Staining with soluble NKG2D-FLAG has been described
8.
NK cells were loaded with indo-1/AM (5 µM) (Sigma, St. Louis) at 37°C for 1h, washed,
incubated with primary mAb (20µg/ml) for 30min at 4°C and washed. The Ca2+ flux was
measured at 37°C using a LSR flow cytometer (Becton Dickinson). Data acquisition was
interrupted for cross-linking with 25µg/ml of goat anti-rat IgG (Sigma) or to add Ionomycin
(1µg/ml).
NK cells (1.5x10
5) were stimulated with 2x10
5 tumor cells (for 6h or 18h) or with plate-
bound  mAb  (for  6h).  Brefeldin  A  (Sigma)  (10µg/ml) was added for the last 3h of
stimulation. IFNγ was determined by intracellular flow cytometry.
Cytotoxicity assays. Standard (4h) 
51Cr release assays were performed as described before
8.
For CHO killing, Ly49D was blocked with anti-Ly49D (4E5) mAb at 10µg per 10
6 effector
cells.
Immunoblot and Immunoprecipitation. Total cell lysates (3x10
6 NK cells) were prepared
in sample buffer (containing 1.5% SDS and DTT). Lysates were boiled at 95°C for 5 min
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and loaded on 16% SDS-PAGE gels. After transfer onto nitrocellulose, immuno blots were
performed with Abs to FcRγ (Upstate), DAP-10 or DAP-12 
10, CD3ζ (H146) and αTubulin
(B-5-1-2, Sigma) followed by HRP-coupled secondary Abs (Southern Biotechnology) and
visualization by ECL (Amersham Bioscience, UK).
NK cells (5x10
6) were incubated anti-NKG2D or anti-Ly49D followed by goat anti-rat Ab.
After washing the cells were lysed in ice-cold 0.2% Dodecyl maltoside lysis buffer (20 mM
Tris-HCl pH 8.2, 100 mM NaCl, 10 mM EDTA, 50 mM NaF, 1 mM Na3VO4) and protease
inhibitor cocktail (Roche, Mannheim, Germany) followed by immunoprecipitation with
Protein  G  Sepharose  (Amersham  Bioscience)  and  anti-rat  IgG  agarose  (Sigma).
Immunoprecipitates were analyzed as above.
Production of recombinant protein. The production of soluble NKG2D has been described
before
8. The extracellular portion including the endogenous leader peptide of H60 (amino
acids 1-213) was amplified by PCR from A20 B cell cDNA, using the following primers
(restriction sites are underlined).
H60 5’ sense actg AAGCTT tgagggaagacc ATG GCA AAG G
H60 3’ anti actg GTCGAC CTG GTT GTC AGA ATT ATG TCG GAA G
The PCR product was directionally cloned into modified PCR-3 vectors (InVitroGen,
SanDiego, CA) to add a COOH-terminal FLAG epitope or to generate a Fc fusion protein
(kindly provided by P. Schneider). The resulting H60-FLAG and H60-Fc constructs were
sequenced to ensure their identity with the published sequences. Fusion proteins were
expressed by transient transfection of 293T cells as before
8.
RT-PCR. Total RNA was extracted using RNeasy (QIAGEN) and cDNA was synthesized
using oligo(dT) priming (Amersham Bioscience) using AMV RT (Roche). PCR primers
were as follows: HPRT 5’ AGT CCC AGC GTC GTG ATT AGC
and  3’ GAC ATC TCG AGC AAG TCT TTC AGT C
Primers for NKG2D-S, NKG2D-L and KARAP/DAP-12 see
11 and for DAP-10 see
7. PCR
amplifications were performed on serial (10-fold) cDNA dilutions.
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RESULTS
Sustained engagement blunts NKG2D function in NK cells.
To determine the impact of sustained engagement on NKG2D function we exposed B6
NK cells to tumor cells expressing NKG2D ligand. RMA cells, which do not express
endogenous NKG2D ligands
8,12 were stably transfected with the high affinity NKG2D ligand
H60 (Fig. 1A). Freshly isolated, T cell depleted NK cells from B6 mice were then activated
with IL-2 in the presence of irradiated RMA-H60 or control RMA cells. Three days later
residual tumor cells and T cells were removed and NK cell reactivity was tested.
RMA-H60 exposed NK cells were almost completely unable to kill RMA-H60 target
cells (Fig. 1B). In contrast, NK cells exposed to control RMA cells efficiently killed RMA-
H60 but, as expected, not the parental RMA cells (Fig.1B). On average 14±5 fold more
RMA-H60 exposed than control NK cells were needed to obtain an equivalent specific lysis
of RMA-H60 cells.
The deficient lysis of RMA-H60 cells was not due to cold target competition. Addition
of unlabeled RMA-H60 cells to control NK cells (at a concentration equivalent to that
remaining after depletion in RMA-H60 co-cultures, usually <5%) had a negligible effect on
the lysis of Cr
51-labeled RMA-H60 cells (Fig.1B).
RMA-H60 exposed NK cells killed CHO (Chinese Hamster Ovary) cells albeit at a
reduced efficiency (Fig.1B). However, RMA-H60 co-culture specifically reduced the Ly49D-
independent part of CHO lysis i.e. the part, which cannot be blocked with anti-Ly49D mAb. If
Ly49D-independent lysis is subtracted, the Ly49D-dependent part of CHO killing remains
essentially unchanged (Fig.1B). Thus, sustained RMA-H60 exposure does not exhaust the NK
cell’s lytic capacity as demonstrated by efficient NK cell activation via Ly49D.
We further determined the time span required to induce NKG2D dysfunction. A
significant, but incomplete inactivation of NKG2D function was already observed when
RMA-H60 cells were present for 24h (Fig.1C). At 48h, the control RMA-exposed NK cells
had increased activity while NKG2D inactivation remained incomplete in RMA-H60 cultures.
At 72h, the NKG2D pathway of RMA-H60 exposed NK cells was completely inactive
(Fig.1C).
The pre-activation of NK cells before the addition of RMA-H60 in vitro (with IL-2 for 3
days) or in vivo (by poly I-C injection) did not prevent NKG2D inactivation (data not shown).
Finally, NK cells inactivation by RMA-H60 occurred also when NK cells were cultured in IL-
12/IL-18 instead of IL-2 (data not shown). These data suggest that NKG2D inactivation
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requires prolonged exposure to RMA-H60 cells and that it is induced irrespective of the NK
cell activation status.
Fig. 1: Chronic engagement abrogates NKG2D function.
A RMA cells stably transfected with the NKG2D ligand H60 bind soluble NKG2D.
B The lytic capacity of NK cells exposed for 3 days to RMA-H60 or control RMA cells
was determined. To exclude cold target competition, unlabeled RMA H60 cells were added
to control NK cells during the lysis assay (at a percentage equivalent to that remaining in the
RMA-H60 cultures (i.e. <5%) (filled squares). These results are from one representative
experiment out of fourteen performed. The lysis curves were shifted relative to the content
of NK cells in the effector cell populations.
To demonstrate the Ly49D dependence of CHO lysis, Ly49D was blocked with mAb 4E5
(gray squares for controls and gray circles for RMA H60 exposed NK cells).
C NK cells were cultured in the presence of IL-2 plus RMA-H60 (gray bars) or RMA cells
(open bars). The lytic activity of NK cells against RMA-H60 was determined after 24, 48
and 72h of co-culture. NK cell activity was tested in triplicate at an E:T of 50 and 10. The
data are representative of two independent experiments.
D NK cells were cultured (for 72h in IL-2) separate from RMA-H60 (filled squares) or
control RMA cells (open squares) using transwell plates. The lytic activity of these NK cells
against RMA-H60 was determined.
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To determine whether direct cell contact was required NK cells and RMA-H60 cells
were separated during the co-culture using transwell plates. This resulted a minimal impact on
NKG2D function (Fig.1D). Similarly, a marginal effect on NKG2D function was observed
when NK cells were exposed to soluble or plastic bound H60-Ig fusion protein, despite the
fact that H60-Ig binds NKG2D based on flow cytometry (not shown). Thus profound NKG2D
dysfunction is dependent on prolonged encounter with ligand in a cellular context.
NK  cells  exposed  to  RMA-H60  for  72h,  in  which  NKG2D  was  completely
dysfunctional, retained 38±12% of the NKG2D cell surface observed on NK cells exposed to
RMA (Fig. 2A and B). Lower NKG2D levels (10 and 22%, again as compared to day3 RMA
exposed NK cells) were observed when NK cells were co-cultured with RMA-H60 for 24 or
48h (Fig. 2B), yet at these time points NKG2D was partially functional (Fig.2B). Finally, the
separation of RMA-H60 and NK cells in transwell plates reduced NKG2D levels to 79% (not
shown), while the effect on NKG2D function was marginal (Fig.1D). Thus the extent of
NKG2D down-modulation is not a very accurate predictive factor for NKG2D function.
Fig. 2 : Phenotype of NK cells exposed to
RMA-H60.
AHistograms show the  expression  of  the
indicated activation receptors or the forward
size scatter (FSC) of control RMA- (open
histogram)  and  RMA  H60-exposed  (gray
histogram) NK cells. Numbers indicate the
mean  fluorescence  intensity  (MFI)  of
staining. The dotted line depicts the FSC of
fresh  splenic  NK  cells.  These  results  are
from one representative experiment out of
six performed.
BBar  graphs  show  the  MFI  of  NKG2D
staining normalized to that of NK cells co-
cultured with control RMA cells for 3 days.
Data for ex vivo isolated NK cells (n=8) and
for the 72h time point (n=12) are compiled
from  numerous  independent  experiments
while individual values (and the mean) from
two independent experiments are shown for
24h  and  48h  of  coculture.  Statistical
significance  of  the  difference  at  72h  of
coculture was evaluated using the one tailed
unpaired student’s t-test *p<0.0001.
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In contrast to NKG2D, other NK cell activation receptors, including Ly49D and NK1.1
were expressed at normal levels (Fig.2A). Notwithstanding, NK cells exposed to RMA-H60
cells expanded on average 2.3 fold less than those co-cultured with RMA (not shown). In
addition their forward scatter (size) was below that of control NK cells, yet clearly increased
as compared to non-stimulated NK cells (Fig.2A). Thus, besides NKG2D function, prolonged
engagement of this receptor also impacts IL-2 driven NK cell growth and expansion.
Sustained NKG2D engagement induces constitutive IFNγ production.
In addition to NKG2D-dependent target cell lysis we tested whether sustained RMA-
H60 exposure impacted IFNγ production. Surprisingly, after 3 days of co-culture with RMA-
H60, a substantial fraction (10-15%) of NK cells were icIFNγ+ even in the absence of any re-
stimulation (Fig. 3). Further, small, but significant amounts of IFNγ were released into the
culture medium (not shown). Thus, the prolonged exposure to RMA-H60 cells induces
constitutive IFNγ production, indicating sustained NKG2D signaling.
The re-stimulation of NK cells, which were previously exposed to control RMA cells,
increased the proportion of icIFNγ+ NK cells approximately 2 fold (Fig.3). In contrast, the re-
stimulation of RMA-H60 exposed NK cells did not further enhance the proportion of icIFNγ+
NK cells (Fig.3). Nevertheless, a robust further increase of the percentage of icIFNγ+ cells
was induced when RMA-H60 exposed NK cells were re-stimulated with anti-Ly49D mAb or
CHO cells (Fig. 3). Thus, chronic exposure to ligand results in the sustained production of
IFNγ production while it blunts NKG2D-dependent target cell lysis.
Fig.  3  : Constitutive  IFNγ  production
by RMA-H60 exposed NK cells.
RMA- (empty bars) and RMA H60-
exposed NK cells (gray bars) were
re-stimulated with the indicated cell
lines or plastic bound mAbs. The bar
graph depicts the mean percentage
(±SD)  of  intracellular  IFNγ
+  NK
cells obtained in 4 to 8 independent
experiments. Statistical significance
of differences between the indicated
groups  were  determined  using  the
two tailed students t-test : *p<0.02,
  **p<0.01,  N.S.  not  significant.  §
p<0.02  as  compared  to  the
corresponding values in the control
RMA-exposed group.
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Basis for defective NKG2D function.
Granule exocytosis is dependent on intracellular mobilization of calcium ([Ca2+]i)
13.
Control, RMA-exposed NK cells showed a robust [Ca2+]i response upon NKG2D cross-
linking. In contrast, [Ca2+]i mobilization was essentially absent in RMA-H60 exposed NK
cells (Fig. 4) suggesting that NKG2D on these NK cells is signaling deficient. In sharp
contrast,  [Ca2+]i  mobilization  was  detected  following  Ly49D  cross-linking.  This  is
consistent  with  the  induction  of  target  cell  lysis  and  IFNγ  production  upon  Ly49D
engagement.  Stimulation  with  the  Ca2+  ionophore  Ionomycin  further  indicated  that
inactivated NK cells have adequate intracellular Ca2+ stores and loading of Indo-1.
Fig.  4  :  Deficient  Ca2+
mobilization by RMA-H60
exposed NK cells
  NK  cells  were  loaded  with
Indo-1 before incubating with
either anti-NKG2D antiserum
or  anti-Ly49D  (4E5)  mAb.
Residual B and T cells were
excluded by gating on CD19-
and CD3-negative cells. The
data  acquisition  was
interrupted  for  cross-linking
the bound mAb with goat anti-
rat IgG. These results shown
are from one experiment out
of two performed.
Sustained NKG2D engagement impacts NKG2D receptor complexes.
Since NKG2D cross linking failed to induce [Ca2+]i mobilization, we next tested
whether NKG2D was associated with its signaling adaptors KARAP/DAP-12 and/or DAP-10
10,11,14.  Co-immunoprecipitation  of  KARAP/DAP-12  or  DAP-10  with  NKG2D  from
inactivated NK cells was below detection. In contrast, both adaptors were readily detected in
association with NKG2D in control NK cells (Fig. 5A). The absence of KARAP/DAP-12 in
immunoprecipitates may be due to a failure to induce the expression of NKG2D-S, the
NKG2D isoform, which can associate with KARAP/DAP-12. However, a semi-quantitative
RT-PCR assay ensured that mRNA for NKG2D-S is present in inactive NK cells (Fig. 5B).
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Thus, the association of KARAP/DAP-12 and DAP-10 signaling adaptors with NKG2D is
below detection, providing first insights into defective NKG2D function.
Significant, but low amounts of KARAP/DAP12 were found in association with Ly49D
in RMA-H60 exposed NK cells (Fig. 5A). The low amounts of adaptor protein are apparently
not limiting for proper Ly49D function. Thus chronic engagement and possibly signaling
affects preferentially the NKG2D receptor complex.
Fig.  5:  Expression  and
function  of  signaling
adaptors.
A NKG2D (top panel)
or  Ly49D  (bottom  panel)
was  immunoprecipitated
from RMA and RMA H60-
exposed  NK  cells.
Immunoprecipitates  were
analyzed using DAP-10 or
KARAP/DAP-12  Abs.
These  results  shown  are
representative  of  two
independent  experiments
performed.
B Total  cellular
mRNA was extracted from
RMA  and  RMA  H60-
exposed  NK  cells.  The
relative  abundance  of
specific  transcripts  was
estimated  by  RT-PCR
analysis  on  serial  10-fold
cDNA  dilutions.  These
results  shown  are
representative  of  five
independent  experiments
performed.
C Immunoblot analysis of total cell lysates of day 3 co-cultures using the indicated Abs.
These results shown are representative of four independent experiments performed.
D KARAPki NK cells were cocultured with RMA (empty circles) or RMA H60 (filled
circles) for 3 days. The lytic activity KARAPki NK cells towards RMA H60 cells was
compared to that of B6 NK cells co-cultured with RMA (empty squares) or RMA H60 (filled
squares). These results shown are representative of two independent experiments performed.
Since low amounts of KARAP/DAP12 were co-immunoprecipitated with Ly49D in
silenced NK cells (Fig. 5A) we further determined the DAP-10 and KARAP/DAP-12 protein
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contents in total NK cell lysates. Remarkably, the abundance of both adaptors was severely
reduced (Fig. 5C). A semi-quantitative RT-PCR assay showed that mRNA for DAP-10 and
KARAP/DAP-12 was approximately equally abundant in inactive and control NK cells (Fig.
5C). Thus, the small pools of cellular DAP-10 and KARAP/DAP-12 adaptor protein are the
result of reduced translation and/or enhanced protein turn over.
In preliminary experiments, we tested whether DAP-10 and KARAP/DAP12 are lost
with similar kinetics upon the exposure of NK cells to RMA-H60 cells. DAP-10 levels were
reduced after 24h of co-culture, whereas KARAP/DAP-12 reduction was evident at 48h (data
not shown). Whereas NKG2D-L is constitutively expressed, in IL-2 stimulated NK cells
NKG2D-S mRNA is expressed at 24h
11. These data are consistent with the interpretation that
due  to  the  inducible  expression  of  NKG2D-S,  NK  cell  activation  via  and  loss  of
KARAP/DAP-12 is delayed as compared to DAP-10.
Based on these findings we further determined the presence of FcRγ and CD3ζ, two
additional signaling adapters used by NK cell activation receptors. Whereas CD3ζ was also
severely diminished in inactive NK cells, FcRγ levels were unperturbed (Fig. 5C). Thus
NKG2D engagement has an unexpectedly broad impact on the abundance of signaling
adaptors in NK cells. Even though CD3ζ does not associate with NKG2D
11 (data not shown),
it is depleted in an NKG2D-induced fashion. The precise connection between CD3ζ and
NKG2D will thus require further investigation.
NK cell inactivation in the absence of KARAP/DAP-12 function.
To address, whether KARAP/DAP-12 function was critical for NK cell inactivation we
used KARAP knock in (KARAPki) mice. In these mice, the ITAM in KARAP/DAP-12 was
rendered non-functional, while the mutant molecule is expressed
7. As compared to B6,
KARAPki NK cells exposed to control RMA showed greatly reduced, yet still significant,
lysis of RMA-H60 targets (Fig. 5D)
11. This residual lysis was NKG2D-dependent since RMA
cells were not killed at all (not shown). Thus short term (3 days) IL-2 activated NK cells can
inefficiently kill via NKG2D in the absence of functional KARAP/DAP-12, likely using
DAP-10, consistent with
10,11,14.
KARAPki NK cells exposed to RMA-H60 cells completely failed to kill RMA-H60
targets (Fig. 5D). Thus NK cell inactivation can occur in the absence of KARAP/DAP-12
function, suggesting that a single signaling adaptor is sufficient for NKG2D inactivation.
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Obviously, this does not exclude the possibility that KARAP/DAP-12 mediates NK cell
inactivation.
Restoration of NKG2D function.
Finally we addressed whether or not the deficient NKG2D function was permanent.
Following the separation of NK cells from RMA-H60 cells and overnight culture in medium
containing IL-2 NK cells readily regained a functional NKG2D pathway as RMA-H60 cells
were now efficiently killed (Fig. 6A).
The functional recovery was associated with a restoration of a normal cell size and
normal NKG2D cell surface levels (not shown). Moreover, the pools of cellular DAP-10,
KARAP/DAP-12 and CD3ζ protein returned to normal (Fig. 6B). Thus, NKG2D dysfunction
is not permanent and continuous presence of NKG2D ligand maintains the inactive state.
Fig. 6: Restoration of NKG2D
function.
A After  3  days  of  co-culture
with  RMA  (open  squares)  or
RMA H60 cells (black circles),
residual  tumor  cells  were
removed  and  NK  cells  were
cultured for an additional 18h
with IL-2. The cytolytic activity
of  these  NK  cells  was
determined towards RMA H60
targets. These results shown are
representative  of  five
independent  experiments
performed.
 B Immunoblots of total cell lysates from “recovered” NK cells using the indicated Abs.
DISCUSSION
Here we show that sustained stimulation with tumor cell-bound ligand uncouples the
NKG2D receptor from the intracellular mobilization of calcium and the exertion of NK cell
mediated cytolysis, while it induces the continuous production of IFNγ. These functional
changes are associated with a low abundance of the NKG2D signaling adaptors DAP10 and
KARAP/DAP12. Since the removal of the stimulating tumor cells restores both NKG2D
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function and adaptor expression, the findings suggest that sustained NKG2D signaling
drastically alters NKG2D function.
The partial inactivation of human NK cells using a brief (6-18h) exposure to K562
tumor target cells has previously been reported
15,16. However, K562 cells engage multiple NK
cell activation receptors including Nkp30, Nkp46 and NKG2D
17. It is thus difficult to draw
conclusions regarding the involvement and/or importance of specific activation pathways for
NK cell inactivation.
The functionality of the NKG2D pathway following ligand exposure has recently been
studied using a co-culture system
6, which is similar to the one shown here. However, the
authors observed a minor (2 fold) negative effect on NKG2D function, while we observed
>10 fold effects, despite a comparable 2-3 fold reduction of NKG2D cell surface levels.
While the affinities of NKG2D for H60 and RAE1ε ligands are comparable
18, B16 melanoma
cells were used before while we used RMA lymphoma cells. The type of NKG2D-ligand
expressing tumor cells may thus be of importance to determine the extent of NKG2D
dysfunction. Consistent with this possibility, the lysis of NKG2D-ligand transduced B16 cells
is  more  dependent  on  DAP-12  than  that  of  ligand-transduced  RMA  cells
1, indicating
qualitative and/or quantitative differences in how NK cells are activated by these two cell
lines.
The NKG2D receptor complex.
Experiments using KARAPki  NK  cells demonstrate that KARAP/DAP-12  is not
necessary for NK cell inactivation via NKG2D. Since DAP-10 is the only known remaining
adaptor normally associated with NKG2D, the experiments suggest that DAP-10 is sufficient
to inactivate NK cells. In this context it is interesting to note that human NKG2D associates
exclusively with DAP-10
19,20, raising the possibility that chronic exposure to NKG2D ligands
may also be sufficient for the inactivation of human NK cells. Obviously, the above data do
not exclude the possibility that NK cell inactivation can be induced via KARAP/DAP-12
signaling.
The transport of NKG2D to the cell surface requires the presence of KARAP/DAP-12
or DAP-10 adaptors
11 (data not shown). However, in inactivated NK cells KARAP/DAP-12
or DAP-10 association with NKG2D was not detected even though significant NKG2D cell
surface expression is detectable. To reconcile these findings it is possible that NKG2D is
transported to the cell surface as NKG2D/adaptor complexes. However, chronic NKG2D
engagement and signaling, which is inline with the constitutive IFNγ production, may disrupt
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NKG2D complexes and result in the continuous loss of the adaptors. Indeed, the dissociation
of transmembrane adapter molecules from multi-chain receptor complexes has been observed
in ligand stimulated TCRs
21. In preliminary experiments, we have attempted to prevent the
loss of adaptor molecules by the addition of inhibitors of lysosomal function. However, the
exposure of primary NK cells to inhibitors resulted in non-specific negative effects on the
expression of signaling adaptors. Heterologous systems may thus be needed to address this
issue.
Alternatively, it is formally possible that an unknown, signaling-incompetent adaptor
may replace KARAP/DAP-12 and DAP-10 in inactivated NK cells. Along these lines, it has
been shown that FcRγ can replace CD3ζ in the TCR complex of chronically stimulated T
cells
22. However, FcRγ did not become part of the NKG2D complex in inactivated NK cells
(data not shown).
Irrespective  of  the  precise  basis,  constitutive  NKG2D  signaling  seems  to  limit
KARAP/DAP-12 and DAP-10 levels. This view is supported by the observation that the
removal of the stimulating tumor cells restores KARAP/DAP-12 and DAP-10 protein
expression and NKG2D-dependent target cell lysis.
Reaction of NK cells to chronic NKG2D stimulation.
Besides KARAP/DAP-12 and DAP-10 we have also noted the loss of CD3ζ  as  a
consequence of sustained NKG2D engagement by tumor cell bound ligand. However, CD3ζ
does not directly associate with NKG2D
11 (data not shown). Therefore, the precise connection
between CD3ζ loss and chronic NKG2D engagement will require further investigation.
However, it is interesting to note that the loss of CD3ζ has also been observed in chronically
activated NK cells and/or T cells in cancer patients, infectious diseases and autoimmune states
(for review see 
23). In essentially all of these instances upregulation of NKG2D ligands has
since then also been documented
4,6,12,24. Since NKG2D is constitutively expressed on human
CD8+ T cells
25 and upon activation on murine CD8+ T cells
12, it will be important to test
whether chronic NKG2D engagement results in DAP-10 loss and/or is involved in CD3ζ loss
in T cells. It is tempting to speculate that CD3ζ loss and NK cell (and/or T cell) dysfunction
reflects in part or entirely the chronic exposure to cells expressing NKG2D ligand.
For personal use only. on November 3, 2014.  by guest    www.bloodjournal.org From 16
Modulation of NK cell activation receptors.
Reduced cell surface expression of specific NK cell activation receptors has first been
reported in humans
26. NK cells with high levels of NCR expression (Natural Cytotoxicity
Receptors i.e. NKp30, NKp44 and NKp46 in humans) display high NK cell activity towards a
variety of target cells, whereas those with low levels showed low NK activity. While NK cells
from occasional healthy donors have a NCR
low phenotype, the majority of patients with acute
myeloid leukemia (AML) display this NCR
low phenotype, which correlates with low NK
activity
27. Similar findings were reported in HIV patients
28. To our knowledge the basis for
the low NCR levels is in most cases unknown. Thus in situations where the levels of NK cell
activation receptors are reduced, it will be important to determine whether or not their
signaling capacity and/or the association with adaptors is preserved.
For NKG2D, down-modulation is induced upon ligand encounter. In this instance,
lower NKG2D expression is observed despite normal expression of the genes coding for
NKG2D and its adaptor genes, suggesting that postranscritptional mechanisms are responsible
to reduce cell surface expression
6 (and shown here). Lower NKG2D cell surface expression is
also observed upon the exposure of NK cells to TGFβ
29,30. In this case, the reduced NKG2D
levels are due to reduced NKG2D gene expression
29.
Activation versus inactivation.
Recent studies have highlighted an important role of NKG2D ligands on murine tumor
models for the induction of anti-tumor immunity
2,3,31,32. Despite this, many NKG2D-ligand
positive tumors progress, providing circumstantial evidence that in vivo NKG2D function may
be impaired at some stage during tumor progression. Indeed, we provide in vitro evidence that
profound NK cell dysfunction can result from the direct and prolonged interaction with tumor
cell bound NKG2D ligand. In addition to tumors, chronic virus infections may generate a
comparable situation. It will thus be crucial to precisely define the factors, which determine the
consequences of NKG2D engagement i.e. reactivity versus inactivity. Answering this question
will be of great value to fully exploit the fact that distressed host cells have the capacity to alert
the immune system.
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